Mubadala

Press Releases

ICLDC: making a difference to diabetes in the UAE

Imperial College London Diabetes Centre (ICLDC), wholly owned by Mubadala Development, opens its doors to its first patients. ICLDC, the UAE’s largest multi-disciplinary facility, is founded on four pillars: treatment, research, training and public health, a model to provide the most comprehensive treatment for diabetes today. As the result of a partnership between Mubadala Development Company and Imperial College London, a world leading science-based university with the largest medical school in Western Europe and with a reputation for excellence in teaching and research, ICLDC is set to bring new hope to those with diabetes in the region.

18 July 2006

Imperial College London Diabetes Centre (ICLDC), wholly owned by Mubadala Development, opens its doors to its first patients. ICLDC, the UAE’s largest multi-disciplinary facility, is founded on four pillars: treatment, research, training and public health, a model to provide the most comprehensive treatment for diabetes today. As the result of a partnership between Mubadala Development Company and Imperial College London, a world leading science-based university with the largest medical school in Western Europe and with a reputation for excellence in teaching and research, ICLDC is set to bring new hope to those with diabetes in the region.

It is estimated that more than a quarter of UAE nationals suffer from diabetes. ICLDC is working to manage and eventually reverse this alarming trend. To achieve this goal, ICLDC aims to increase diabetes understanding through research and enhancing awareness in the region.

HE Khaldoon Khalifa Al Mubarak, Managing Director & CEO of Mubadala Development and ICLDC Chairman, believes the centre will provide a unique and significant contribution to diabetes care. HE states: “Our vision is to improve the quality of life for those with diabetes as well as helping to prevent diabetes in those with a predisposition. By doing so, we hope to reverse the alarming prevalence that is affecting the UAE and the region.”

Who is at risk of developing diabetes? Almost anyone. Those at increased risk include individuals who have a history of diabetes in their family, people over 40, those who are overweight or obese and inactive individuals.

ICLDC stands as the UAE’s largest specialized diabetes resource which combines all facets of research and treatment under one roof. Encompassing a premier Treatment Centre which hosts an extensive team of specialized staff, the centre is dedicated to meeting patient needs efficiently on every level. The world-class Research Facility, headed by renowned Imperial College London researchers, aims to find mechanisms to slow down and reverse the prevalence of diabetes and allows ICLDC doctors to remain updated with latest evidence-based treatments and developments. http://www.icldc.ae